Voya Investment Management LLC Ovid Therapeutics Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.72 - $4.04 $10,820 - $16,071	-3,978 Reduced 14.84%	22,819 $69,000
Q4 2023 Feb 14, 2024	BUY	$2.98 - $3.78 $2,896 - $3,674	972 Added 3.76%	26,797 $86,000
Q2 2023 Aug 14, 2023	BUY	$2.53 - $3.89 $65,337 - $100,459	25,825 New	25,825 $84,000
Q2 2021 Aug 16, 2021	SELL	$3.3 - $4.49 $78,015 - $106,148	-23,641 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $8,612 - $15,908	3,559 Added 17.72%	23,641 $95,000
Q4 2020 Feb 16, 2021	BUY	$2.28 - $6.84 $11,931 - $35,793	5,233 Added 35.24%	20,082 $46,000
Q2 2020 Aug 14, 2020	BUY	$2.67 - $7.91 $39,646 - $117,455	14,849 New	14,849 $109,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.